These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17976991)

  • 1. Tau isoform expression in frontotemporal dementia without tau deposition.
    Sutherland GT; Nowak G; Halliday GM; Kril JJ
    J Clin Neurosci; 2007 Dec; 14(12):1182-5. PubMed ID: 17976991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia.
    Hu WT; Parisi JE; Knopman DS; Boeve BF; Dickson DW; Ahlskog JE; Petersen RC; Josephs KA
    Alzheimer Dis Assoc Disord; 2007; 21(4):S39-43. PubMed ID: 18090422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation.
    Lippa CF; Zhukareva V; Kawarai T; Uryu K; Shafiq M; Nee LE; Grafman J; Liang Y; St George-Hyslop PH; Trojanowski JQ; Lee VM
    Ann Neurol; 2000 Dec; 48(6):850-8. PubMed ID: 11117541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.
    Zhukareva V; Sundarraj S; Mann D; Sjogren M; Blenow K; Clark CM; McKeel DW; Goate A; Lippa CF; Vonsattel JP; Growdon JH; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2003 May; 105(5):469-76. PubMed ID: 12677447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
    Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
    J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.
    Rosso SM; Donker Kaat L; Baks T; Joosse M; de Koning I; Pijnenburg Y; de Jong D; Dooijes D; Kamphorst W; Ravid R; Niermeijer MF; Verheij F; Kremer HP; Scheltens P; van Duijn CM; Heutink P; van Swieten JC
    Brain; 2003 Sep; 126(Pt 9):2016-22. PubMed ID: 12876142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing of amino-terminal Tau mRNA in rat spinal cord during development and following axonal injury.
    Halverson RA; Chambers CB; Muma NA
    Exp Neurol; 2001 May; 169(1):105-13. PubMed ID: 11312563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between tau H2 haplotype and age at onset in frontotemporal dementia.
    Borroni B; Yancopoulou D; Tsutsui M; Padovani A; Sawcer SJ; Hodges JR; Spillantini MG
    Arch Neurol; 2005 Sep; 62(9):1419-22. PubMed ID: 16157749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progranulin null mutations in both sporadic and familial frontotemporal dementia.
    Le Ber I; van der Zee J; Hannequin D; Gijselinck I; Campion D; Puel M; Laquerrière A; De Pooter T; Camuzat A; Van den Broeck M; Dubois B; Sellal F; Lacomblez L; Vercelletto M; Thomas-Antérion C; Michel BF; Golfier V; Didic M; Salachas F; Duyckaerts C; Cruts M; Verpillat P; Van Broeckhoven C; Brice A;
    Hum Mutat; 2007 Sep; 28(9):846-55. PubMed ID: 17436289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
    Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain tau expression and correlation with the H1/H1 tau genotype in frontotemporal lobar degeneration patients.
    Lladó A; Ezquerra M; Gaig C; Sánchez-Valle R; Tolosa E; Molinuevo JL
    J Neural Transm (Vienna); 2007; 114(12):1585-8. PubMed ID: 17661153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of APOE and tau gene variability on risk of frontotemporal dementia.
    Bernardi L; Maletta RG; Tomaino C; Smirne N; Di Natale M; Perri M; Longo T; Colao R; Curcio SA; Puccio G; Mirabelli M; Kawarai T; Rogaeva E; St George Hyslop PH; Passarino G; De Benedictis G; Bruni AC
    Neurobiol Aging; 2006 May; 27(5):702-9. PubMed ID: 15904995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.
    Sobrido MJ; Miller BL; Havlioglu N; Zhukareva V; Jiang Z; Nasreddine ZS; Lee VM; Chow TW; Wilhelmsen KC; Cummings JL; Wu JY; Geschwind DH
    Arch Neurol; 2003 May; 60(5):698-702. PubMed ID: 12756133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
    Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age.
    Lambourne SL; Humby T; Isles AR; Emson PC; Spillantini MG; Wilkinson LS
    Hum Mol Genet; 2007 Jul; 16(14):1708-19. PubMed ID: 17517691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative neurofilament light and tau immunostaining in frontotemporal dementia.
    Sjögren M; Englund E
    Dement Geriatr Cogn Disord; 2004; 17(4):346-9. PubMed ID: 15178951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of pathologic subtypes of behavioral--variant frontotemporal dementia.
    Hu WT; Mandrekar JN; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Hutton M; Dickson DW; Josephs KA
    Arch Neurol; 2007 Nov; 64(11):1611-6. PubMed ID: 17998443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.